Trials / Unknown
UnknownNCT02648906
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 56 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy and safety of Choline alfoscerate and Donepezil for cognitive improvements of patients with cerebrovascular injury in Alzheimer patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Choline alfoscerate | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2018-11-01
- First posted
- 2016-01-07
- Last updated
- 2016-11-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02648906. Inclusion in this directory is not an endorsement.